Review: Chitosan based Hydrogel polymeric beads - as drug delivery system

BioResources

Volumn 5, Issue 4, 2010, Pages 2765-2807

  Rani, Manjusha ^a   Agarwal, Ariuja ^a   Negi, Yuvraj Singh ^b  

^a JV Jain College   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

Author keywords

Chitosan; Drug delivery system; Drug release; Hydrogel; Polymeric bends

Indexed keywords

CHITOSAN DERIVATIVES; DEACETYLATION; DRUG DELIVERY SYSTEM; DRUG LOADING; DRUG RELEASE; DRUG SOLUBILITY; DRUG-POLYMER INTERACTION; GRAFT COPOLYMERIZATION; MEDICAL FIELDS; POLYMERIC BEADS; POLYMERIC BENDS; POTENTIAL APPLICATIONS; PREPARATION METHOD; STRUCTURAL EFFECT; SUSTAINED RELEASE; SYNTHETIC POLYMERS;

ACETYLATION; BIOCOMPATIBILITY; BIODEGRADABLE POLYMERS; CHITOSAN; DRUG INTERACTIONS; DRUG PRODUCTS; FUNCTIONAL POLYMERS; HYDROGELS; NATURAL POLYMERS; TISSUE;

CONTROLLED DRUG DELIVERY;

EID: 80051567744     PISSN: None     EISSN: 19302126     Source Type: Journal    
DOI: None     Document Type: Article

References (282)

1. Agnihotri, S. A., and Aminabhavi, T. M. (2004). "Controlled release of clozapine through chitosan microparticles prepared by a novel method," J. of Controlled Release 96. 245-259.
2. Agnihotri, S. A., and Aminabhavi. T. M. (2006). "Novel interpenetrating network chitosan-poly (ethylene oxide-g-acryl amide) hydrogel microspheres for the controlled release of Capecitabiue," Int. J. Pharm. 324. 103-115.
3. Agnihotri, S. A. Mallikarjuna. N. N., and Aminabhavi, T. M. (2004). "Recent advances on chitosan - based micro and naaoparticles in drug delivery," Journal of Controlled Release 100, 5-28.
4. Aiedeh. K. and Taha, M. O. (1999). "Synthesis of chitosan succinate and chitosan phthalate and their evaluation as suggested matrices in orally administered, colon specific drug delivery systems," Arehiv. der Pharmazie 332, 103-107.
5. Aktas, Y. Audrieux, K., Alonso, M. J., Calvo, P., Giirsoy, R. N. and Convreur, P. (2005). "Preparation and in vivo evaluation of chitosan uanoparticles containing a caspase inhibitor,"Int. J. Pharm. 298. 378-383.
6. Alaxakis, T., Boadi, D. K. Quong. D. Groboillot, A., O'Neill, I., Poncelet, D., and Neufeld, R. J. (1995). "Microencapsulation of DNA within alginate microspheres aud crosslinked chitosan membranes for in vivo application," Appl. Biachem. Biotech. 50, 93-106.
7. Alpar, H. O., Eyles. J. E., Williamson. E. D., and Somaravapu. S. (2001). "Iutranasal vaccination against plaque tetanus and diphtheria," Advanced Drug Delivery Reviews 51, 173-201.
8. Alsarra, I. A.,Neau, S. H., and Howard, M. A. (2004). "Effects of preparative parameters on the properties of chitosan hydrogel beads containing Candida rugosa lipase," Biomaterials 25, 2645-2655.
9. Alvarez-Lorenzo. C, and Concheiro, A. (2002). "Reversible adsorption by a pH and Temperature-sensitive acrylic hydrogel," J. Control Release 80, 247-257.
10. Amaral, I. F., Lamghari, M, Sousa, S. R., Sampaio, P., and Barbosa, M. A. (2005a). "Rat bone marrow stromal cell osteogenic differentiation and fibronecetin adsorption ou chitosan membranes: The effect of degree of acetylation," Journal of Biomedical Materials Research 75A, 387-397.
11. Amaral, I. F., Sampaio. P., and Barbosa. M. A. (2005b). "Three-dimensional culture of human osteoblastic cells in chitosau sponges; The effect of the degree of vaccination against plaque tetanus and diphtheria," Advanced Drug Delivery Reviews 51, 173-201.
12. Alsarra, I. A.,Neau, S. H., and Howard, M. A. (2004). "Effects of preparative parameters on the properties of chitosan hydrogel beads containing Candida rugose: lipase." Biomaterials 25, 2645-2655.
13. Alvarez-Lorenzo, C, and Concheiro, A. (2002). "Reversible adsorption by a pH and Temperature-sensitive acrylic hydrogel," J. Control Release 80, 247-257.
14. Amaral, I. F., Lamghari, M., Sousa, S. R., Sampaio, P., and Barbosa, M. A. (2005a). "Rat bone marrow stromal cell osteogenic differentiation and fibronecetin adsorption ou chitosan membranes: The effect of degree of acetylation," Journal of Biomedical Materials Research 75A, 387-397.
15. Amaral, I. F., Sampaio. P. and Barbosa. M. A. (2005b). "Three-dimensional culture of human osteoblastic cells in chitosau sponges: The effect of the degree of acetylation." Journal of Biomedical Materials Research 76A, 335-346.
16. Amidi, M., Romeijn. S. G., Coos Verhoef, J., Junginger, H. E., Buugener, L., Huckriede, A., Crommelm, D. J. A., and Jiskoot, W. (2007). "N-Tnmethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for iutranasal vaccination: Biological properties and immunogenicity in a mouse model," Vaccine 25, 144-153.
17. Amiji. M., and Park, K. (1994). "Surface modification of polymeric biomaterials with poly(ethylene oxide) - A steric repulsion approach," In: Polymers of Biological and Biomedical Significance, Shalaby, S. W., Ikada. Y., Langer, R. and Williams. J. (eds.), ACS Symposium Series 540, Amer. Chem. Soc, Washington, DC, 135-146.
18. Anal, A. K. Bhopatakar, D., Tokura, S., Tamura, H., and Stevens, W. F. (2003). "Chitosan -Alignate multilayers beads for gastric passage and controlled intestinal release of protein," Drug. Dev. Ind. Pharm. 29, 713-724.
19. Aral, C, and Akbuga. J. (1998). "Alternative approach to the preparation of chitosau Beads." International Journal of Pharmaceutics 168, 9-15.
20. Artursson. P., landmark, T., Davis. S. S., and Ilium, L. (1994). "Effect of cliitosan on the permeability of monolayers of intestinal epithelial cells (CACO-2)," Pharm. Res. 11, 1358-1361.
21. Ashori. A., Raverty. W. D. Jalauddin. H. Wan Md. Zin. W. Y., and Mohd Nor. M. Y. (2006). "Effect of cliitosan addition on the surface properties of keuaf (Hibiscus camiabimis) paper," Iranian Polymer Journal 14(9), 807-814.
22. Atyabi. F. Majzoob, S., Imau, M, Salehi. M., and Dorkoosh. F. (2005). "In vitro evaluation and modification of pectinate gel beads containing trimethyl cliitosan, as a multipnrtieulate system for delivery of water soluble macromolecule to colon," Carbohydrate, Polymer 61. 39-51.
23. Bamba, M., Pusieusx, F., Maxty, J. P., and Constensen, J. T. (1979). "Release mechanisms in gel forming sustained release preperations," Int. J. Pharm. 2, 307-315.
24. Baxter, A., Dillion, M., Taylor. K. D. A., and Roberts, G. A. F. (1992). "Improved method for IR determination of the degree ofN-acetylation of cliitosan," Int. J, Biol. Macromol. 14,166.
25. Berger. J., Reist, M., Mayer, J.M., Felt, O., and Gurny, R. (2004a). "Structure and interactions in cliitosan hydrogels formed by complexatiou or aggregations for biomedical applications," European Journal of Pharmaceutics and Biopharmaceutics 57, 35-52.
26. Berger, J., Reist, M., Mayer, J. M., Felt, O., Peppas, N. A., and Gurny, R. (2004b). "Structure and interactions in covaleutly and ionically crosslinked cliitosan hydrogels for biomedical applications," European Journal of Pharmaceutics and Biopharmaceutics 57, 19-34.
27. Bernkop-Schnurch, A. (2000). "Cliitosan and its derivatives: Potential excipients for peroral peptide delivery systems." International Journal of Phannaceutics 194. 1-13.
28. Bernkop-Schimrch. A., and Kast, C. E. (2001). "Chemically modified chitosans as enzyme inhibitors." Advanced Drug Delivery Review 52, 127-137.
29. Borchard. G. (2001). "Chitosans for gene delivery." Adv. Drug Delivery Rev. 52, 145-150.
30. Borzacchielo, A. Ambrosio, L. Netti. P. A., Nicolais, L., Peniche, C, Gallardo, A., and San Roman, J. (2001). "Chitosau-based hydrogels: Synthesis and characterization," J. Mater. Sci. Mater. inMed. 12, 861-864.
31. Brouwers, J. R. B. (1996). "Advanced and controlled drug delivery systems in clinical disease management," J. Pharm World Sci. 18, 153-162.
32. Calvo, P., Remunan-Lopez, C. Vila-Jato, J. L,. and Alonso, M. J. (1997b). "Cliitosan and chitosan/etliylene oxide- propylene oxide block copolymer uanoparticles as novel carriers for protein and vaccines," Pharm Res. 14. 1431-1436.
33. Calvo. P., Remunan-Lopez, C, Vila-Jato, J. L., and Alonso, M. J. (1997a). "Novel hydrophilic chitosan-poly (ethylene oxide) naiioparticles as protein carriers," J. Applied Polymer Sci. 63, 125-132.
34. Calvo, P., Vila-Jato, J. L., and Alonso. M. J. (1996). "Comparative in vitro evaluation of several colloidal systems, uanoparticles, nanocapsules and naiioenmlsions as ocular drug earners," J. Pharm. Sci. 85, 530-536.
35. Chandy, T., and Sharma, C. P. (1990). "Cliitosan - as a biomaterial," Biomater. Artifi. Organs 18. 1.
36. Chandy. T., and Sharma, C. P. (1991). "Biodegradable chitosan matrix for the controlled release of steroids," Biomater. Artif. Cells Immobilization Biotechnol. 19, 745.
37. Chandy. T. and Shanua, C. P. (1992). "Chitosan beads and granules for oral sustained delivery of nifedipine: In vitro studies." Biomaterials 13, 949-952.
38. Chandy, T., Sharma, C. P. (1993). "Chitosan matrix for oral sustained delivery of Ampicillin," Biomaterials 14. 939-944.
39. Chandy. T., Sharma. C. P. and Sunny, M. C. (1987). "Inhibition of platelet adhesion to glow discharge modified surfaces," J. Biomater. Appl. 1. 533-552.
40. Chang, J., and Zliongguo, S. Y. (1996). "Application of nanoparticles in controlled release of anticancer drugs: Preparation and evaluation in vitro of methotrexate-o-carboxymethylate chitosan nanoparticles," Chinese J. Biomed. Eng. 15, 102-106.
41. Chen, F., Zhang, Z. R., and Huang, Y. (2007). "Evaluation and modifications of N-trimethyl chitosan chloride nanoparticles as protein carriers," Int. J. Pharm. 336, 166-173.
42. Chen, R. H., and Hwa, H. D. (1996). "Effect of molecular weight of chitosan with the same degree of deacetylatiou on the thermal mechanical and permeability properties of the prepared membrane," Carbohydrate Polymer 29, 253-260.
43. Chen, X. G., Lee, C. M., and Park, H. J. (2003). "O/W emulsificatron for the self aggregation and nanoparticles formation of linoleic acids modified chitosan in the aqueous system," J. Agric. Food Chem. 51, 3135-3139.
44. Chew, J. L., Wolfowicz. C. B., Mao, H. Q., Leong, K. W., and Chua, K. Y. (2003). "Chitosan iianoparticles containing plasmid DNA encoding house dust mite allergen, Dei pi for oral vaccination in mice," Vaccine 21, 2720-2729.
45. Chien, Y. (1982). "Novel drug delivery system," In: Fundamentals of Controlled Release Drug Administration, Swarbrick, J. (ed.). Marcel Dekker, Inc., New York. 465-474.
46. Cobby, J., Mayersohn, M., and Walker, G. C. (1974). "Influence of shape factors on kinetics of drug release from matrix tablets. II. Experimental," J. Pharm. Sci. 63. 732-737.
47. Conti, B., Giunchedi. P. Genta, I, and Conte, U. (2000). "The preparation and in vivo evaluation of the wound healing properties of chitosau microspheres," STP Pharma. Sci. 10, 101-104.
48. Conti, B., Modena, T., Genta, I., Perugini, P., Decano, C, and Pavanetto, F. (1998). "Microencapsulation of cefylpyridinium chloride with a bioadhesive polymer," Proc. Int. Symp. Control. Release Bioact. Mater. 25, 822-823.
49. Coppi. G. Lannuccelli. V. Leo, E., Bemabei, M. T. and Cameroni. R. (2001). "Chitosan-aliguate microparticles as a protein carrier," Drug Dev Ind Pharm. 27, 393-400.
50. Cui, Z., and Mumper. R. J. (2001). "Chitosan-based naiioparticles for topical genetic immunization," J. Control Release 75. 409-419.
51. Curti, E., Britto, D. D., and Campana-Filho, S. P. (2003). "Methylation of chitosan with iodomethane: Effect of reaction conditions on chemoselectivity and degree of substitution," Macromol. Biosci. 3, 571-576.
52. Damom, O. Gueugniard, P. Y., Berthiu-Maghit, M., Saintigny, G. Chretien. F., and Berthod. F. (1994). "A dermal substrate made of collagen-GAG chitosan for deep burn coverage: First clinical uses," Clinical Mater. 15. 273-276.
53. Danielsen. S. Varum. K. M., and Stokke, B. T. (2004). "Structural analysis of chitosan medicated DNA condensation by AFM: Influence of chitosan molecular parameters," Biomacromolecules 5, 928-936.
54. De Campos, A. M., Sanchez, A., and Alonso, M. J. (2001). "Chitosau nanoparticles: A new vehicle for the improvement of the delivery of drug to the ocular surface. Applications to cyclosporine A," Int. J. Pharm. 224, 159-168.
55. Delben, F., Gabrielli, P., Muzzarelli, R. A. A., and Stefancich, S. (1994). "Interaction of soluble chitosans with dyes in water. II. Thenuodynaniic data," Carbohydrate Polymer 24,25-30.
56. Di Colo, G. D., Zambito, Y., Burgalassi, S., Serafmi, A., and Saettone, M. F. (2002). "Effect of chitosan on in vitro release and ocular deliver of ofloxaciu from erodible inserts based on poly (ethylene oxide)." Int. J.Pharm. 248, 115-122.
57. Domard, A. (1986). "Circular dichroism study onN- acetylglucosamine oligomers," Int. J. Biol. Macromol. 8, 243.
58. Domard, A. (1987). "pH and c.d. measurements on a fully deacetylated chitosan: Application to Cu II -polymer interactions." Int. J. Biol. Macromol. 9, 98-104.
59. Du, J. Dai. J., Liu. J. L., and Dankovich, T. (2006). "Novel pH-sensitive polyelectrolyte carboxymethyl konjac glucomamiaii-chitosan beads as drug carriers." Reactive & Functional polymers 66, 1055-1061.
60. Dunn, E. J., Zhang, X., Sim, D., and Goosen, M. F. A. (1993). "Synthesis of N-(aminoalkyl) chitosan for microcapsules," Journal Applied Polymer Science 50. 353-365.
61. Dutta, P. K. and Ravi Kmnar, M. N. V. (1998). "Textiles industries: Safety, health and environment," In: Trivedy, R. K. (ed.), Advances in Wastewater Treatment Technologies, Global Science, India, p. 229.
62. Elcin, Y. M., Dixit, V., and Gitnick. G. (1996). "Controlled release of endofhelial cell growth factor from chitosan-albuinin microspheres for localized angiogenesis: In vitro and in vivo studies," Artif. Cells Blood Snbstit. Immobile, Biotechnol. 24(3). 257-271.
63. Erbacher, P. Zou. S. Beuinger, T., Steffan, A. M., and Remy, J. S. (1998). "Chitosan based vector /DNA complexes for gene delivery: Biophysical characteristics and transactoin ability," Reactive & Functional polymers 66, 1055-1061.
64. Femandez-Hervas, M. J., and Fell, J. T. (1998). "Pectin /chitosan mixtures as coatings for colon-specific dmg delivery: an in vitro evaluation," Bit. J. Pharm. 169. 115-119.
65. Fernandez- Urrusuno, R., Calvo, P., Reimman-Lopez, C, Vila-Jato, J. L., and Alonso, M. J. (1999). "Enhancement of nasal absorption of insulin using chitosan nanoparticles," Pharm. Res. 16. 1576-1581.
66. Florea. B. I., Thanou, M, Geldof. M. Meauey, C. Junginger, H. E., and Borchard. G. (2000). "Modified chitosau oligosaccharides as tiansfection agents for gene therapy of cystic fibrosis."Proc. Int. Symp. Control. Release Bioact. Mater. 27, 846-847.
67. Gan, Q., Wang, T., Coclrrane, C, and McCarron, P. (2005). "Modulation of surface charge particle size and morphological properties of chitosan - TPP nanoparticles intended for gene delivery." Colloids Smfaces B 44, 65-73.
68. Geuta, I. Constautini, M., Asti, A., Conti. B., and Montanari, L. (1998). "Influence of glutaraldehyde on dmg release and mucoadhesive properties of chitosan microspheres," Carbohydrate Polym. 36(2-3), 81-88.
69. George, M, and Abraham. T. E. (2006). "Polyionic hydrocolloids for the intestinal delivery of protein drags, alginate and chitosan - A review," J. Control Release 114, 1-14.
70. Gibaldi, M. and Feldman. S. (1967). "Establislunent of sink conditions in dissolution rate determinations: Theoretical considerations and application to non disintegrating dosage forms," J. Pharm. Sci. 56, 1238-1242.
71. Giunchedi, P., Geuta, I, Conti. B., Muzzarelli, R. A. A., and Conte. U. (1998). "Preparation and characterization of ampicillin loaded methyl pyrrolidinone chitosan and chitosan microsplieres," Biomaterials 19, 157-161.
72. Goldsmith, J. A., Randall, N., and Ross, S. D. (1978). "On methods of expressing dissolution rate data," J. Pharm. Pharmacol. 30, 347-349.
73. Graham, N. B. (1990). "Controlled drug delivery systems," Chem Ind. 15, 482-486.
74. Gupta. K. C, and Ravi Kumar, M. N. V. (2000b). "Semi-interpenetrating polymer network beads of crosslinked chitosan-glycine for controlled release of chlorphenramine maleate," J. Appl Poly. Sci. 76, 672-683.
75. Gupta. K. C, and Jabrail, F. H. (2006). "Glutaraldebyde and glyoxal crosslinked chitosan microspheres for controlled delivery of centchroman." Carbohydrate Researdi 341, 744-756.
76. Gupta. K. C, and Ravi Kumar, M. N. V. (2000a). "Drug release behavior of beads and microgranules of dritosan," Biamaterials 21, 1115-1119.
77. Gupta. K. C, and Ravi Kumar, M. N. V. (2000c). "Preparation, characterization and release profiles of pH-sensitive chitosan beads," Polymer International 49, 141-146.
78. Gupta. K. C, and Ravi Kumar, M. N. V. (2001b). "pH dependent hydrolysis and drag release behavior of chitosan/poly(ethylene glycol) polymer network microspheres," J. of Materials Science: Materials in Medicine 12, 753-759.
79. Gupta. K. C, and Ravi Kumar, M. N. V. (2001a). "Studies on semi-interpenetrating polymer network beads of chitosan poly (ethylene glycol) for controlled release of drags." J. Applied Polymer Science 80. 639-649.
80. Hari, P. R., Chandy, T., and Sharma. C. P. (1996). "Chitosan/calcium-alginate beads for oral delivery of insulin," J. of Applied Polymer Science 59, 1795-1801.
81. Harland, R. S., Gazzaniga. A. Sangalli. M. E., Colombo, P., and Peppas, N. A. (1988). "Drug/polymer matrix swelling and dissolution." Pharm Res. 5, 488-494.
82. 2nd Edition, Society of Dyers and Colorists, West Yorkshire, UK, p. 255.
83. Hayashi, T. and Ikada, Y. (1991). "Protease immobilization onto porous chitosan beads," J. Appl. Poly. Sci. 42, 85.
84. He. P., Davis. S. S., and Ilium, L. (1998). "In vitro evaluation of the mucoadhesive properties of chitosau microspheres,"Int. J, Pharm, 166, 75-88.
85. He. P., Davis. S. S., and Ilium, L (1999). "Sustained release chitosan microspheres prepared by novel spray drying methods," J. Microencapsidation 16, 343-355.
86. Hejazi, R. and Amiji, M. (2002). "Stomach-specific auti-H pylori therapy. I: Preparation and characterization of tertracyclme-loaded chitosan microspheres." Int. J. Pharm. 235, 87-94.
87. Hejazi, R., and Amiji, M. (2003). "Chiosan-based gastrointestinal delivery systems," J. Controlled Release 89, 151-165.
88. Helander, I. M., Nunniaho-Lassila, E. L., Ahvenaineu, R. Rhoades. J., and Roller. S. (2001). "Chitosan disrupts the barrier properties of the outer membrane of gram negative bacteria." International journal of Food Microbiology 71, 235-244.
89. Hench, L.L. (1998). "Biomaterials a forecast for the future." Biomaterials 19(16), 1419-1423.
90. Higuchi, T. (1961). "Rate of release of medicaments from ointment bases containing drugs in suspension," Pharm. Set. 50, 874-875.
91. Higuchi, T. (1963). "Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices," J. Pharm. Sci. 52, 1145-1149.
92. Hisamitsu, I., Kataoka, K., Okano, T., and Sakurai, Y. (1997). "Glucose responsive gels from phenylborate polymer and poly (vinylakohol): Prompt response at physiological pH through the interaction of borate with ammo group in gel," Pharm. Res. 14, 289-293.
93. Hixson, A. W., and Crowell, J. H. (1931). "Dependence of reaction velocity upon surface and agitation." Ind. Eng. Chem. 23, 923-931.
94. Holappa, J., Nevalainen, T., Savolainen, J. Soininen. P., Elomaa, M., Safin, R., et al. (2004). "Synthesis and characterization of chitosan N-betainates having various degree of substitution." Macromolecules 37. 2784-2789.
95. Holappa, J. Nevalainen, T. Soininen, P., Elomaa, M., Safin, R., Masson, M., et al. (2005). "N-chloroacyl-6-o-tripheiiylniethylcliitosaiis; Useful intermediates for synthetic modifications of chitosan," Biomacromolecules 6, 858-863.
96. Holappa. J., Nevalainen. T., Soininen. P. Masson, M., and Jarvinen, T. (2006). "Synthesis of novel quaternary chitosan derivatives via N-chloroacyl-6-o-triphenylmethylchitosans." Biomacromolecules 7. 407-410.
97. Huguet, M. L., Groboillot, A. Neufeld. R. J. Poncelet. D., and Dellacherie. E. (1994). "Hemoglobin encapsulation in chitosan/caleium alginate bead," J. Applied Polymer Science 51, 1427-1432.
98. Ilium, L. (1998). "Chitosau and its use as pharmaceutical excipient," Pharm. Res. 15, 1326-1331.
99. Ilium, L. (2003). "Nasal drug delivery -possibilities, problems and solutions," J. of ControlledRelease 87, 187-198.
100. Ilium, L, Jabbal-Gill, I., Hinchcliffe, M, Fisher, A. N. and Davis, S. S. (2001). "Chitosan as a novel nasal delivery systems for vaccines." Adv. Drug Deliv. Rev. 51, 81-96.
101. Ito, M. Ban, A., Ishihara, M. (2000). "Anti-ulcer effects of chitin and chitosan, healthy foods, in rats," Jpn. J. Pharmacol 82, 218-225.
102. Iqbal, M., Lin, W.; Jabbal Gill. I., Davis, S. S. Steward, M. W. and Ilium, L. (2003). "Nasal delivery of chitosan - DNA plasmid expressing epitopes of respiratory syncytial vims (RSV) induces protective CTL responses in BALB/C mice," Vaccine 21, 1478-1485.
103. Iwasaki. N., Yamane. S. T., Majima, T., Kasahara, Y., Minami, A. Harada. K., et al. (2004). "Feasibility of polysaccharide hybrid materials for scaffolds in cartilage tissue engineeriug:evaluation of chondrocyte adhesion to polyion complex fibres prepared from alginate and chitosau," Biomacromolecules 5, 828-833.
104. Jabbal-Gill, I, Fisher, A. N., Rappuoli. R., Davis, S. S., and Ilium, 1. (1998). "Stimulation of mucosal and systemic antibody responses against Bordetellapertusis filamentous haemagglutiniii and recombinaut pertussis toxin after nasal administration with chitosan in mice," Vaccine 16, 2039-2046.
105. Jae, H. P., Yong, W. C, Hesson, C, Ick, C. K., and Seo, Y. J. (2003). "Synthesis and characterization of sugar-bearing chitosan derivatives: Aqueous solubility and biodeeiadability," Brotnacroniolectttes 4, 1087-1091.
106. Jagur-Grodzinski, J. (1999). "Biomedical application of functional polymers." React. Funct. Polym. 39,99-138.
107. Jameela, S. R., and Jayakrislmau. A. (1995). "Glutaraldehyde crosslinked chitosan microspheres as a long acting biodegradable drug delivery vehicle: Studies on the in vitro release of mitoxautrone and in vivo degradation of microspheres in rat muscles," Biomaterials 16, 769-775.
108. Jameela, S. R., Kumary, T. V., Lala, V., and Jayakrishuan, A. (1998). "Progesterone loaded chitosan microspheres: A long acting biodegradable controlled delivery system," J. Controlled Release 52, 17-24.
109. Jameela, S. R., Latha, P. G., Subramoniam. A., and Jayakrishnan, A. (1996). "Antitumor activity of mitoxantrone- loaded clutosau microspheres against Ehrlich ascites carcinoma," J. Pharm Pharmacol. 48, 685-688.
110. Jameela, S. R., Misra, A., and Jayakrislman, A. (1994). "Crosslinked chitosan microspheres as carriers for prolonged delivery of macromolecular drags," J. Biomaterial Set. Pofym. Ed. 6, 621-632.
111. Janes. K. A., Calvo, P., and Alonso, M. J. (2001a). "Polysaccharide colloidal particles as delivery systems for macmmolecules," Advanced Drug Delivery Reviews 47, 83-97.
112. Janes. K. A., Fresneau, M. P., Marazuela. A. Fabra, A., and Alonso. M. J. (2001b). "Chitosan nanoparticles as delivery systems for doxombicin," Control Release 73. 255-267.
113. Jayakumar, R. Reis. R. L., and Mano. J. F. (2007). "Synthesis and characterization of pH sensitive thiol- containing chitosan beads for controlled drug delivery applications." Drug Delivery 14,9-17.
114. Jeong, Y. I. Cheon. J. B. Kim. S. H., Nan. J. W., and Lee, Y. M. (1998). "Chlonazepam release from core shell type nanoparticles in vitro," J. Control Release 51, 169-178.
115. Judson. I. R., Beale. P. I, Tngo, J. M., Aheme, W., Crompton, T., Jones, D., Bush, E. and Reigner, B. (1999). "A human capecitabine excretion balance and pharmaco-kinetic study after administration of a single oral dose of 14C-labelled drug," Invest. New Drugs 17, 49-56.
116. Jung, T., Kamm, W., Breitenbach, A., Kaiserling, E., Xiao, J. X., and Kissel, T. (2000). "Biodegradable nanoparticles for oral delivery of peptides: Is there a role for polymers to affect mucosal uptake?," Eur J Pharm Biopharm. 50. 147-160.
117. Kashyap, N., Viswanad, B. Shanna. G. Bhardwaj. V. Ramarao, P., and Ravi Kumar, M. N. V. (2007). "Design and evaluation of biodegradable biosensitive in situ gelling system for pulsatile delivery of insulin," Biomaterials 28. 2051-2060.
118. Kawashima, Y., Handa, T., Kasai, A., Takenaka, H., and Lin, S. Y. (1985). "The effect of thickness and hardness of the coating film on the drug release of tlieophylline granules," Chem Pharm Bull 33, 2469-2474.
119. Khor, E., and Lim, L. Y. (2003). "Implantable applications of chitin and chitosan," Biomaterials 24, 2339-2349.
120. Knorr, D. (1983). "Dye binding properties of chitin and chitosan." J. Food Sci. 48(1). 36-37.
121. Knorr, D. (1982). "Functional properties of chitiu and chitosan," J. Food Sci. 47, 593-595.
122. Knorr, D. (1991). "Recovery and utilization of chitin and chitosan in food processing waste management." Food Technol. Jan. 114-122.
123. Kojuji, K., Akamine, H., Qiau, C. J., Watauabe, K. Torgau, Y., Nislmniira, M., Sugiyama, I. Murata. Y. and Kawashima, S. (2004). "Therapeutic efficacy of sustained drug release from chitosan gel on local inflammation," Int. J. Pharm. 272(1-2), 65-78.
124. Koopmans, S. J., Slips. H. C, Krans, H. M. and Radder, J. K. (1996). "Pulsatile intravenous insulin replacement m streptozotocin diabetic rats is more efficient than continuous delivery: Effects on glycaemic control, insulin-medicated glucose metabolism and lipolysis," Diabetologia 39. 391-400.
125. Korsemeyer, R. Gumy, R., and Peppas. N. (1983). "Mechanisms of solute release from porous hydrophilic polymers," Int. J. Pharm. 15, 25-35.
126. Kost. J. (ed.), (1990). Pulsed and Self Regulated Drug Delivery, CRC Press. Boca Raton.
127. Kost, J., and Langer. R., in: Peppas N. A. (ed.). (1987). Hydrogels in Medicines and Pharmacy, CRC Press, Boca Raton, p. 95.
128. Kotze, A. F. Lueben. H. L., De Boer, A. G. Verhoef. I C. and Junginger. H. E. (1999) "Chitosan for enhanced intestinal permeability: Prospects for derivatives soluble in neutral and basic environments," Eur. J. Pharm. Sci. 7, 145-151.
129. Krauland. A. H., Guggi. D. and Bernkop-Sclmurch, A. (2006). "Thiolated chitosan microparticles: A vehicle for nasal peptide drug delivery," International Journal of Pharmaceutics 307, 270-277.
130. Kreuter, J. (1983). "Evaluation of nanoparticles as drag delivery system. I. Preparation methods," Pharm Acta Heiv. 58. 196-209.
131. Kreuter, J. (1998). "Recent advances in uanoparticles and nanospheres," In: Hincal, A. A., and Kas, H. S. (eds.)," Biomedical Science and Technology, Plenum Press, New York, 31-39.
132. Kulkarni. V., Kulkami, P. V., and Keshavayya, J. (2007). "Glutaraldelryde-crosslinked chitosan beads for controlled release of diclofenac sodium," J. Appl. Poly. Sci. 103, 211-217.
133. Kumar, V., and Kothari, S. H. (1999). "Effect of compressional force on the crystallimty of directly compressible cellulose excipients," Int. J. Pharm. 177(2). 173-182.
134. Kumari, K. and Kuudu, P. P. (2007). "Semi-interpenetrating polymer networks (IPN) of chitosan and L-alanine for monitoring the release of cnlorplieniramine maleate," J. Applied Polymer Science 103, 3751-3757.
135. Kumari, K. and Kuudu, P. P. (2008). "Studies on in vitro release of CPM from semi-mterpenetrating polymer network (IPN) composed of chitosan and glutamic acid," Bull. Mater Sci. 31(2), 159-167.
136. Kurita, K., Ikeda, H., Yoshida, Y., Shimojoh, M. and Harata, M. (2002). "Chemoselective protection of the ammo group of chitosau by controlled phtlialoylation: Facile preparation of a precursor useful for chemical modifications," Biomacromolecules 3, 1-4.
137. Labhasetwar. V., Song. C, and Levy, R. J. (1997). "Nauoparticle drug delivery system," Adv. Drug Del. Rev. 24, 63-85.
138. Langenbucher, F. (1988). "Linearization of dissolution rate curves by the Weibull distribution." J. Pharm. Pharmacol. 24, 979-981.
139. Lauger. R. (1998). "Drag delivery and targeting," Nature 392, 5-10.
140. Lee, H. W., Park. Y. S., Jung, J. S., and Shin, W. S. (2002). "Chitosan oligosaccharides, dp 2-8, have prebiotic effect on the bifidobacterium bifidium and lactobacillus Sp," Anaerobe 8.319-324.
141. Lee, K.Y., Kwon, I. C, Kim, Y., Jo, W., and Jeong, S. Y. (1998). "Preparation of chitosan self aggregates as a gene delivery system," J. Control Release 51. 213-220.
142. Lehr, C. M., Boustra. J. A., Schacht, E. H., and Jimginer. H. E. (1992). "In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers." Int. J. Pharm 78, 43-48.
143. Li, B., and Xie. B. (2004). "Synthesis and characterization of konjac glucomaimau /poly viny alcohol interpenetrating polymer networks," J. Appl. Poly. Sci. 93, 2775-2780.
144. Li, X., Tushima, Y., Morimoto, M., Saimoto, H., Okamoto, Y., Minarni, S., and Shigemasa. Y. (2000). "Biological activity of chitosan-sugar hybrids: Specific interaction with lectin," Polymers for Advanced Technologies 11, 176-179.
145. Li, Z. Zhuang, X. P. Liu, X. F., Guau. Y. L., and Yao, K. D. (2002). "Study on antibacterial o-carboxymetliylated chitosan/cellulose blend film from LiCl/N, N- dimethylacetamide solution." Polymer 43. 1541-1547.
146. Lim, S. H., and Hudson, S. M. (2003). "Review of chitosan and its derivativaes as antimicrobial agents and their uses as textile chemicals," J. Macromol. Sci. Poly. Rev. C43(2), 223-269.
147. Lim, S., and Hudson, S. M. (2004). "Synthesis and antimicrobial activity of a water soluble chitosan derivative with a fiber reactive group." Carbohydrate Res. 339. 313-319.
148. Lim, S. T., Forbes, B. Berry, D. J., Martin, G. P., and Brown, M. B. (2002). "In vivo evaluation of novel hyaluronanchitosan delivery system for the nasal delivery of gentamicin in rabbits," Int. J. Pharm. 231, 73-82
149. Lin, Y. H., Chung, C. K., Chen, C. T., Liang, H. F., Chen, S. C, and Sung, H. (2005). "Preparation of nanoparticles composed of chitosan /poly -γ- glutamic acid and evaluation of their permeability through Caco-2 cells," Biomacromolecules 6, 1104-1112.
150. Liu, C. G., Desai, K. G. H., Chen, X. and Park. H. (2005). "Lmolemc acid modified chitosan for formation of self assembled nanoparticles," Journal of Agricultural and Food Chemistry 53, 437-441.
151. Liu, X. F. Gvian. Y. L., Yang, D. Z., Li, Z., and Yao, K. D. (2001). "Antibacterial action of chitosan and carboxymethylated chitosan," J. Appl. Poly. Sci. 79, 1324-1335.
152. Lubbeu, M. V. D. Van Opdoip. F. A. C. Hengeveld, M. R., Onderwater, J. J. M, Koerten, H. K., Verhoef, J. C, Borchard, G., and Juugiuger, H. E. (2002). "Transport of chitosan microparticles for mucosal vaccine deliveiy in a human intestinal M-cell model," J. Drug Target. 10, 449-456
153. Maclaughliu, F. C, Mumper, R. J., Wang. J., Tagliaferri, J. M., Gill, I., Hinchcliffe, M. and Rolland, A. P. (1998). "Cliitosan and depolymerized chitosan oligomers as condensing caniers for in vivo plasmid deliveiy," J. Controlled Release 56. 259-272.
154. Mageiilieim, B. and Benita, S. (1991). "Nanoparticle characterization: A comprehensive physicochemical approach." S.T.P. Pharm. Sci. 1, 221-224.
155. Maghami, G. G. and Roberts. G. A. F. (1988). "Studies on the adsorption of anionic dyes on chitosan." Makromol. Chem. 189(10), 2239-2243.
156. Mani Prabaharan. (2008). "Chitosan derivatives as promising materials for controlled drug delivery," J. of Biomaterials Applications 23(1), 5-36.
157. Mansoun, S., Lavigne, P., Corsi, K., Benderdour, M., Beaumont, E., et al. (2004). "Chitosan-DNA nanoparticles as non viral vectors in gene therapy: Strategies to improve transfection efficacy." Eur. J. Pharm. Biopharm. 57, 1-8.
158. Mao, H. Q., Roy. K., Trouug-Le. V. L. Janes. K. A., Lim. K. Y., Wang. Y. August, J. T. and Leong. K. W. (2001). "Chitosan DNA nanoparticles as gene deliveiy caniers: Synthesis, characterization and transfectiou efficiency," J. Control Release 70, 399-421.
159. Mao, J. S. Zhao. L. G. Yao, K. D. Shang. Q. X. Yang, G. H., and Cao. Y. L. (2003). "Study of novel chitosan-gelatin artificial skin in vitro." J. Biomed. Mater. Res Part A 64A, 301-308.
160. Markey. M. L., Bowman. M. L. Bergamini, M. V. W. (eds.). (1989). Chitin and Chitosan, Elsevier Applied Science, London, p.713.
161. Marsano, E., Biaiichi, E., Vicini, S. Compagnino, L. Sioiikowska. A. Skopiiiska. J., and Wisniewski, M. (2005). "Stimuli responsive gels based on interpenetrating network of chitosan and poly (vinylpyrrolidone)." Polymer 46, 1595-1600.
162. McNeela, E. A., Jabbal-Gill, I, Ilium, L., Pizza, M., Rappuoli, R., Podda, A., Lewis, D. J. M. and Mills. K. H. G. (2004). "Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans. Enhancement of Th2 responses and toxin neutralizing antibodies by formulation with chitosan." Vaccine 22, 909-914.
163. McNeela. E. A., O'Coimar, D., Jabbal-Gill, L, Ilium, L., Davis, S. S. Pizza. M. Peppoloni, S., Rappuoli, R., and Mills, K. H. G. (2000). "A inucosal vaccine against diphtheria: Formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following delivery," Vaccine 19(9-10), 1188-1198.
164. Mi, F. L., Shyu. S. S. Chen, C. T. and Schoung,.T.Y. (1999b). "Porous chitosan microspheres for controlling the antigen release of new castle disease vaccine: Preparation of antigen-absorbed microsphere and in vitro release." Biamaterials 20, 1603-1612.
165. Mi, F. L., Shyu. S. S., Wong, T. B., Jang, S. F., Lee, S. T., and Lu, K. T. (1999a). "Chitosan polyelectrolyte complexation for the preparation of gel beads and controlled release of anticancer drug. II. Effect of pH dependent ionic crosslinkiug or interpolymer complex using tripolyphosphate or polyphosphate as reagent," J. Appl. Poly. Sci. 74, 1093-1107.
166. Mi, F. L. Sung, H. W., and Shyu, S. S. (2002a). "Drug release from chitosau-alginate complex beads reinforced by a naturally occurring crosslinking agent." Carbohydrate Polymers 48, 61-72.
167. Mi. F. L., Tan. Y. C, Liang, H. F. and Sung, H. W. (2002b). "In vivo biocompatibility and degradability of a novel injectable chitosan based implant." Biomaterials 23, 181-191.
168. Mitra, S., Gaur. U., Ghosh, P. C. and Maitia, A. N. (2001). "Tumor targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan uanoparticles as carrier," J. Control Release 74, 317-323.
169. Mitra, S. B., In: Shalaby, S. W. Hoffman, A. S., Ratiier, B. D., and Horbett. T. A., (eds). (1984). Polymers as Biomaterials, Plenmn Press, New York, p. 293.
170. Moritani, T., and Alvarez-Lorenzo, C. (2001). "Conformational imprinting effect ou stimuli-sensitive gels made with an imprinter monomer," Macromolecules 34. 7796-7S03.
171. Mumper, R. J. Wang, J., Claspell, J. M., and Rolland. A. P. (1995). "Novel polymeric condensing carriers for gene delivery." Proc. hit. Symp Controlled Release. Bioactive Mater.22, 178-179.
172. Murata, Y., Sasaki, N., Miyamoto, E., and Kawashiina, S. (2000). "Use of floating alginate gel beads for stomach-specific drag delivery." European Journal of Pharmaceutics and Biopharmaceutics 50. 221-226.
173. Muzzarelli, R. A. A. (1992). "Depolymerization of metliylpynolidiiione chitosan by lysozyme," Carbohydrate Polymer 19. 29-34.
174. Muzzarelli, R. A. A. (1988). "Carboxymethylated chitius and chitosans," Carbohydrate polymers 8, 1-21.
175. Muzzarelli, R. A. A. (1997). "Human enzymatic activities related to the therapeutical administration of chitosan derivatives." Cell Mol. Biol. Life Sci. 53, 131-140.
176. Muzzarelli, R. A. A., Baldssarre, V., Conti, F., Gazzauelli, G., Vasi, V., Ferrara, P., and Biagini, G. (1988). "The biological activity of chitosau ulfrastrucfural study." Biomaterials 8, 247-252.
177. Muzzarelli, R. A. A., Lough. C, and Emanuelli, M. (1987). "The molecular weight of chitosan studied by laser light scattering." Carbohydr. Res. 164. 433-442.
178. Muzzarelli, R. A. A., Tanfani. F. and Emanuelli. M. (1984). "Chitin and its derivatives: New trends of applied research," Carbohydrate Polymers 3. 53-75.
179. Nair, K. G. R., Madhavan, P. (1984). "Chitosau for removal of mercury from water," Fishery Tech. 21. 109-112.
180. Nicol, S. (1991). "Life after death for empty cells," New scientist Feb. 46.
181. Niola, F., Basora, N., Chomet. E., and Vidal. P. F. (1983). "A rapid method for the determination of the degree of N- acetylation of chitin- chitosan sample by acid hydrolysis and HPLC," J. Therm. Anal. 28, 189-195.
182. Nishimura, K., Nishimura, S., Seo, H., Nishi, N, Tokura, S., and Azuma, I. (1986). "Macrophage activation with multiporous beads prepared from partially deacetylated chitin," Biomed. Mater. Res. 20, 1359-1372.
183. Nishimura, S. I. Kohgo, O. Kurita, K., and Kuzuhara, H. (1991). "Chemospecific manipulations of a rigid polysaccharide: Synthesis of novel chitosan derivatives with excellent solubility in common organic solvents by regioselective chemical modifications," Macromolecules 24, 4745-4748.
184. Ohya, Y. Takei. T., Kobayashi. H. and Ouchi. T. (1993). "Release behaviour of 5-fluorouracil from chitosan gel microspheres immobilizing 5-fluoromacil derivative coated with polysaccharide and their cell specific recognition." J. Microencapstdation 10. 1-9.
185. Okamoto. Y. Minami, S. Matsuhashi. A., Saimoto, H., Shigemasa, Y., Tanigawa, T., Tanaka, Y. and Tokura, S. (1992). "Applications of chitin and chitosan in large animal practice," In: Adances in Chitin and Chttosan, Brine, C. J., Sandrof P. A., and Zizakis. J. P. (eds.). Elsevier: New York. 61-69.
186. Onishi, H., Oosegi, T., and Machida, Y. (2008). "Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobeuzenesulfonic acid-induced colitis," Int. J. Pharm. 358, 271-277.
187. Onishi, H., Oosegi, T., Machida. Y. and McGinity, J. W. (2005). "Preparation and in vitro evaluation of chitosan microspheres containing prednisolone: Comparison of simple and conjugate microspheres," Drug. Dev. Ind. Pharm. 31, 597-605.
188. Oosegi. T., Onishi, H., and Machida, Y. (2008). "Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan - Preduisolone conjugate microspheres in rats with TNBS-induced colitis," Int. J. Pharm. 348, 80-88.
189. Pangburn. S. H., Trescony, P. V. and Heller, J., In: Zikakis J. P. (ed.). (1984). "Chitin, chitosan and related enzymes," Harcourt Brace Jcmovich, New York, P. 3.
190. Pantaleone, D., Yalpani, M., and Scollar, M. (1991). "Adances in chitin and chitosan," In: Brine. C. J. Sandrof P. A., and Zizakis, J. P., Proceed 5th Int Couf. Chitin and Chitosan, Princeton New York.
191. Park, J. H., Cho, Y. W., Son. Y. J., Kim, K., Chung, H. Jeong. S. Y., Choi, K., Park, C. R., Park, R. W., Kim, I. S., and Kwon, I. C. (2006). "Preparation and characterization of self-assembled nanoparticles based oil glycol chitosan bearing adriamyciii," Colloid Polymer Sci. 284, 763-770.
192. Park, Y. K., Park, Y. H., Shin. B. A., Choi, E. S., Park, Y. R. Akaike. T., and Cho, C. S. (2000). "Galactosylated chitosan graft-dextran as hepatocyte-targeting DNA carrier," J. Control Release 69, 97-108.
193. Patel, V. R. and Amiji, M. M. (1996). In: Ottenbrite, R. M, Huang. S. J., and Park, K. (eds.). Hydrogeh and Biodegradable Polymers for BioappHcations, ACS Symposium series, Vol. 627. American Chemical Society. Washington DC, 209-220.
194. Pathak. C. P., and Barman, S. P. (2003). "Multiblock biodegradable hydrogels for drag delivery and tissue treatment," United States Patent 6,639,014.
195. Pavis, H., Wileock, A., Edgecombe, J., Carr, D., Manderson, C, Church, A., and Fisher, A. (2002). "Pilot study of nasal morphine chitosan for the relief of break through pain in patients with cancer," J. Pain Sympt. Manag. 24, 598-602.
196. Peniche. C, Arguelles-Monal. W. Davidenko. N. Sastre, R., Gallardo, A., and San Roman. J. (1999). "Self-curing membranes of chitosan/PAA IPNs obtained by radical polymerization preparation characterization and interpolymer complexation," Biomaterials 20, 1869-1878.
197. Peniche. C, Fernandez. M. Gallardo, A. Lopez-Bravo, A., and San Roman, J. (2003). "Drug delivery systems based on porous chitosan /polyacrylic acid microspheres," Macromol. Biosci. 3, 540-545.
198. Peppas, N. A. (1985). "Analysis of Fickian and non-Fickian drug release from Polymers," Pharm Acta. Helv. 60. 110-111.
199. Peppas, N. A., Bures, P., Leobandung, W., and Ichikawa, H. (2000). "Hydrogels in pharmaceutical formulations," Eur. J. pharm. Biopharm. 50. 27-46.
200. Peppas. N. A., and Korsmeyer. R. W. (1987). "Dynamically swelling hydrogels in controlled release applications," In: Peppas, N. A. (ed.), Hydrogels in Medicine and Pharmacy, Vol. 3. CRC Press. Boca Raton. FL. 103-136.
201. Peppas. N. A., and Sahlin, J. J. (1989). "A simple equation for the description of solute release III coupling of diffusion and relexation," Int. J, Pharw. 57, 169-172.
202. Podual, K., Doyle III, F. J., and Peppas. N. A. (2000b). "Preparation and dynamic response of cationic copolymer lrydrogels containing glucose oxidase," Polymer 41, 3975-3983.
203. Podual. K. Doyle III, F. J., and Peppas, N. A. (2000a). "Dynamic behavior of glucose oxidase-coutaiuing microparticles of poly (ethylene glycol)-grafted cationic hydiogels in an environment of changing pH," Biomaterials 21, 1439-1450.
204. Polk. A. Arnsden. B., de Yao. K. Peng, T. and Goosen, M. F. A. (1994). "Controlled release of albumin from chitosan alginate microcapsules," J. Pharm. Sci. 83, 178-185.
205. Pornsak, S. (1996). "Delivery systems for peptide and protein drugs," Warasan Phesatchasat, 23, 1-12.
206. Raathke. T. D. and Hudson, S. M. (1993). "Determination of the degree of N-deacetylation in chitiii and chitosan as well as their monomer sugar ratios by near infrared spectroscopy." J. Polym Sa. Poly. Chem. Ed. 31(3), 749-753.
207. Rani, M., Agarwal, A., Maharana, T., Negi, Y.S. (2010). "A comparative study for interpenetrating polymeric network (IPN) of chitosan-amino acid beads for controlled drug release," African Journal of Pharmacy and Pharmacology 4(2). 035-054.
208. Rao, K. S. V. K., Naidu, B. V. K., Subha, M. C. S., Sairam, M, and Amiuabhavi, T. M. (2006). "Novel chitosau-based pH-seusitive interpenetrating network microgels for the controlled release of cefadroxil," Carbohydrate Polymers 66. 333-344.
209. Ravi Kumar, M. N. V. (2000). "A review of chitin and chitosan applications," Reactive and Functional Polymers 46. 1-27.
210. Ravi Kumar. M. N. V., Dutta, P. K., and Nakamura, S. (1998). "Methods of metal capture from waste water," In: Trivedy, R. K. (ed.), Advances in Waste Water Treatment Technologies, Global Science. India, p. 22.
211. Ravi Kumar, M. N. V., Rajakala Sridhari. T., Durga Bhavani, K., and Dutta, P.K. (1998). "Trends in color removal from textile mill effluents," Colorage 40, 25-34.
212. Raymond, L., Morin, F. G. and Marchessault, R. H. (1993). "Degree of deacetylatiou of chitosan using couductometric titration and solid state NMR," Carbohydr. Res. 243, 331.
213. Reis, C. P., Neufeld, R. J., Ribeiro. A. J., and Veiga, F. (2006). "Nanocapsulation I. Method for preparation of drug-loaded polymeric nanoparticles," Nanomedicine Nanotechnology Biology and Medicine 2, 8-21.
214. Risbud. M. V., Hardikar, A. A., Bhat, S. V., and Bhonde, R. R. (2000). "pH-sensitive freeze dried chitosan polyviuyl pyrrolidone hydrogels as controlled release system for antibiotic delivery." Journal Control Release 68, 23-30
215. Ritger, P. L., and Peppas, N. A. (1987). "A simple equation for description of solute release. II. Fickian and anomalous release from sivellable devices," J. Control. Release 5, 37-42.
216. Rokhade. A. P., Agnihotri, S. A. Patil, S. A. Mallikarjuna. N. N, Kulkarni, P. V. and Aininabhavi, T. M. (2006). "Semi-interpenetrating polymer network microspheres of gelatin and sodium carboxymethyl cellulose for controlled release of ketorolac tromethamine," Carbohydrate Polymers 65, 243-252.
217. Rokhade, A. P. Shelke, N. B., Patil, S. A., and Aininabhavi, T. M. (2007). "Novel interpenetrating polymer network microspheres of chitosan and methylcellulose for controlled release of theophylline." Carbohydrate Polymer 69, 678-687.
218. Romero, P. Costa. J. B. and Chulia. D. (1991). "Statistical optimization of a controlled release formulation obtained by a double compression process: Application of a Hadamard matrix and a factorial design," In: Wells, J. I., Rubinstein, M. H., and Horwood, E. (eds.), Pharmaceutical Technology, Controlled Drug Release, Ellis Harwood, New York, 2, 44-58.
219. Roy, K., Mao, H. Q., Huang, S. K., andLeong, K. W. (1999). "Oral gene delivery with chitosan-DNA nanoparticles generates inmiunologic protection in a marine model of peanut allergy," Nat. Med. 5, 387-391.
220. Ruel-Gariepy, E., Shive, M., Bichara. A. Benada. M., Le Garrec, D., Chenite. A., et al. (2004). "A thermosensitive chitosan-based hydrogel for the local delivery of Paclitaxel," European Journal of Pharmaceutics and Biophamiaceittics 57, 53-63.
221. Sashiwa, H., Saimoto, H., Shigemasa, Y., Ogawa, R. and Tokura, S. (1991). "Distribution of the acetamido group in partially deacetylated chitins," Carbohydrate Polymer 16. 291.
222. Sashiwa. H., Saimoto, H., Shigemasa, Y., and Tokura, S. (1993). "N-Acetyl group distribution in partially deacetylated chitins prepared imder homogenous conditions," Carbohydrate Res. 242, 167.
223. Sashiwa, H., Shigemasa, Y., and Roy, R. (2000). "Chemical modification of chitosan. Part 2 - Novel N-alkylation of chitosan via Michael type reaction," Client Lett. 862-863.
224. Sashiwa, H., Yamamori. N., Ichinose, Y., Sunamoto. J., and Aiba, S. (2003). "Michael reaction of chitosan with various acryl reagents in water," Biomacromolecules 4, 1250-1254.
225. Schellekens, R., and Bastiansen. C. J. (1991). "A drawing behaviour of poly vinyl alcohol fibres," Journal of Applied Polymer Sci. 43, 2311-2315.
226. Schipper, N. G. M., Varum, K. M, Stenberg, P., Ocklind, G., Leimemas, H., and Aitmsson, P. (1999). "Chitosan as absorption enhancers of poorly absorbable drugs. 3. Influence of mucus as absorption enhancement," Fur. J. Pharm Sci. 8, 335-343.
227. Schnurch, A. B. Humenberger. C, and Valenta, C. (1998). "Basic studies on bioadhesive delivery systems forpeptide and protein drugs," Int. J. Pharm. 165, 217-225.
228. Sezer, A. D., and Akbuga, J. (1999). "Release characteristics of chitosan treated alginate beads: 11. Sustained release of a low molecular drug from chitosan treated alginate beads," Journal of Microencapsulation 16. 195-203.
229. Shiino, D., Murata, Y., Kubo, A., Kim, Y. J., Kataoka, K., Koyama, Y., et al. (1995). "Amine containing phenylboronic acid gel for glucose-responsive insulin release under physiological pH," J. Control Rel. 37, 269-276.
230. Shikata, F. Tokmnitsu, H., Ichikawa, H., andFukumori, Y. (2002). "In vilro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron capture therapy of cancer." Eur. J. Pharm. Biopharm. 53, 57-63.
231. Shiraishi, S., Imai. T., and Otagiri, M. (1993). "Controlled release of indoinethacin by chitosan-polyelectrolyte eoniplex: Optimization and in vivo/in vitro evaluation," J. of Controlled Release 25. 217-225.
232. Shu, X. Z. and Zhu, K. J. (2000). "A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery," International J. of Pharmaceutics 201, 51-58
233. Skorik, Y. A., Gomes. C. A. R., Vasconcelos. M. T. S. D. and Yatluk, Y. G. (2003). "N-(2-carboxyethyl) chitosans: Regioselective synthesis, characterization and protolytic equilibria," Carbohydrate Research 338, 271-276.
234. Slepian, M. J., and Massia, S. P. (2001). "Local polymeric gel cellular therapy," United States Patent 6, 290-729.
235. Song, Y., Ouishi, H., Machida. Y., and Nagai. T. (1996). "Drug release and autitumor characteristics of N-Succinyl-chitosan initoinycin C as an implant." J. Controlled Release 42,93-100.
236. Soppimath, K. S., Aminabhavi, T. M, Dave, A. M., Kumbar, S. G., and Rudzinski, W. E. (2002). "Stimulus-responsive smart hydrogels as novel drag delivery systems." Drug. Dev, bid. Pharm 28. 957-974.
237. Soppimath, K. S., Ammabhavi, T. M, Kulkarm, A. R. and Rudzmski, W. E. (2001). "Biodegradable polymeric nanoparticles as drag delivery devices," Journal of Controlled Release 70, 1-20.
238. Sosulski, F. W. (1962). "The centrifugation method for determining flour absorption in hard red spring wheats," Cereal Chem. 39, 344-348.
239. Sperling. L. H. (1981). Interpenetrating Polymer Network and Related Materials, Plenum Press. New York, P. 1.
240. Spreen, K. A. Zikakis. J. P. and Austin. P. R. (1984). In Zikakis, J. P. (ed.) Chitin and Chitosan and Related Enzymes. Academic Press Oralando p. 57
241. Stone, C. A. Wright, H., Clarke, T. Powell. R., and Devaraj, V.S. (2000). "Healing at skin graft donor sites dressed with chitosan." Br. J. Plastic Surg. 53. 601-606.
242. Sujja-Areevath, J., Munday, D. L,. Lox. P. J. and Khan, K. A. (1998). "Relationship between swelling, erosion and drug release from hydrophilic natural gum mini matrix formulation." Em: J, Pharm. Sci. 6. 207-217.
243. Sun, Y., and Wan, A. (2007). "Preparation of nanoparticles composed of chitosan and its derivatives as delivery system for macromolecules," J. Appl. Poly. Sci. 105, 552-561
244. Surini. S. Akiyama, H., Morishita, M. Nagai, T., and Takayama. K. J. (2003). "Release phenomena of insulin from an implantable device composed of a polyion complex of chitosan and sodium hyaluronate," J. of Controlled Release 90. 291-301.
245. Takeuchi, H., Thongborisute, J., Matsui, Y., Sunhara, H., Yamamoto, H., and Kawashima. Y. (2005). "Novel mucoadhesion tests for polymers and polymer coaled particles to design optimal mucoadhesive drug delivery systems," Advanced Drug Delivery Reviews 57, 1583-1594.
246. Tapia, C, Escobar, Z., Costa, E., Sapag-Hagar, J., Valenzuela, F., Basualto, C, et al. (2004). "Comparative studies on polyelectrolyte complexes and mixtures of chitosan -alginate and chitosan-carrageeuan as prolonged diltiazem chlorhydrate release systems." European Journal of Pharmaceutics and Biopharmacentics 57. 65-75.
247. Thanou, M, Verhoef, J. C, Marbach. P., and Juuginger, H. E. (2000). "Intestinal absorbtiou of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo," J. Pharm. Sci. 89, 951-957.
248. Thierry. B., Kujawa, P. Tkaezyk. C, Wimiik, F. M. Bilodeau, L., and Tabrizian, M. (2005). "Delivery platform for hydrophobic dmgs: Prodmg approach combined with self-assembled multilayer," Journal of the American Chemical Society 127, 1626-1627.
249. Tokumitsu, H., Hiratsuka, J. Sakurai, Y., Kobayashi. T., Ichikawa. H. and Fiikimiori, Y. (2000). "Gadolinium neutron capture therapy using novel gadopenetic acid chitosan-complex nanopaitides: In vivo growth suppression of experimental melanoma solid tumor," Cancer Lett. 150, 177-182.
250. Tozaki, H., Odoriba, T. Okada, N., Fujita, T., Terabe, A., Suzuki, T., Okabe, S., Muranishi, S., and Yamamoto, A. (2002). "Chitosan capsules for colon-specific drug delivery enhanced localization of 5-amino salicylic acid in the large intestine accelerates healing of TNBS-mduced colitis in rats," Controlled Release 82, 51-61.
251. Tsai, G. J., and Su, W. H. (1999). "Antibacterial activity of shrimp chitosan against Escherichia coli" Journal of Food Protection 62, 239-243.
252. Tseng. H. Furhata, K. and Sakamoto, M. (1995). "Bromination of regenerated chitin with N-bromosuccinimide and tri-phenylphosphine under homogeneous conditions in lithium bromide-N.N-dimethylacetainide," Carbohydr. Res. 270(2), 149-161.
253. Uhrich, K. E., Cannizzaro, S. M., Langer, R. S., and Shakesheff, K. M. (1999). "Polymeric systems for controlled drug release," Chem. Rev. 99, 3181-3198.
254. Van der Lubben, I. M., Kersten, G., Fretz, M. M, Beuveiy, C, Verhoef, J. C, and Jimginger, H. E. (2003). "Chitosan micro particles formucosal vaccination against diphtheria oral and nasal efficacy studies in mice," Vaccine 21, 1400-1408.
255. Van der Lubben. I. M., Konings, F. A. J., Borchard. G. Verhoef. J. C. and Juuginger. H. E. (2001a). "In vivo uptake of chitosan microparticles by murine peyer's patches: Visualization studies using confocal laser scanning microscopy and iinimmo-histochemistry." J. Drug larger 9, 39-47.
256. Van der Lubben. I. M, Verhoef, J. C, Van Aelst. A. C, Borchard. G. and Jimginger, H. E. (2001b). "Chitosan microparticles for oral vaccination: Preparation, characterization and preliminary in vivo uptake studies in murine peyer's patches." Biomateriah 22, 687-694.
257. Van der Merwe, S. M., Verhoef, J. C, Kotze, A. F., and Juiigmger. H. E. (2004). "N dimethyl chitosan chloride as absorption enhancer in oral peptide ding delivery. Development and characterization of minitablet and granule formulations," European Journal of Pharmaceutics and Biopharmaceulics 57, 85-91.
258. Vandorpe, J., Schacht, E., et al. (1997). "Long circulating biodegradable poly (phosphazene) nanoparticles surface modified with poly(phosphazene)-poly ethylene oxide co-polymer," Biomateriah 18, 1147-1152.
259. Vudathala. G. K., and Rogers, J. A. (1992). "Dissolution of fludrocortisone from phos-pholipid coprecipitates," J. Pharm. Sci. 81, 282-286.
260. Wagner. J. G. (1969). "Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules," J. Pharm. Sci.58, 1253-1257.
261. Wang, K., and He. Z. (2002). "Alginate-konjac gluconiannau-chitosan beads as controlled release matrix," International J. of Pharmaceutics 244, 117-126.
262. Washington. C. (1990). "Drug release from microdisperse systems, A critical Review," Int J. Pharm. 58, 1-12
263. Weber, W. B. (1992). Phvsicochemical Process for Wastewater Control, Wiley, New York.
264. Wei, Y. C. and Hudson. S. M. (1993). "Binding of sodium dodecyl sulfate to a polyelectrolyte based chitosan," Macromolecules 26, 4151.
265. Westeriiik. M. A. J., Smithson, S. L., Srivastava, N. Blonder, J. Coeshott. C, and Rosenthal. G. J. (2002). "Projuvant (Pluronic F 127)/chitosan) enhances the immune response to intranasally administered tetanus toxic." Vaccine 20, 711-723.
266. Wong, K., Sun, G., Zhang, X., Dai, H., Liu, Y., He, C, et al. (2006). "PEI-g-chitosan, a novel gene delivery system with transfection efficiency comparable to polyethyleneimine in vitro and after liver administration in vivo," Bioconjugate Chemistry 17, 152-158
267. Wu, A. C. M. (1998). "Determination of molecular weight distribution of chitosan by high performance liquid chroinatography, methods," Methods Enzymol.161, 447-452
268. Xu, Y. M., and Du, Y. M. (2003). "Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles," Int. J. Pharm. 250, 215-226
269. Yalpani. M., Johnson, F. and Robinson. L. E. (1992). Chitin, Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications, Elsevier, Amsterdam.
270. Yao, K. D., Peng, T., Feng, H. B., and He. Y. Y. (1994). "Swelling kinetics and release characteristics of crosslinked chitosau-polyether polymer network (semi IPN) hydrogels," J. Pofym. Sci. Part A: Polym. Chem. 32, 1213-1223.
271. Yao, K. D. Peng, T. Yu, J. J., Xu, M. X., and Goosen, M. F. A. (1995). "Microcapules /Microspheres releated to chitosan," J. M. S - Rex-. Macromol. Chem. Phys. C35, 155.
272. Yao, K. D. Yin, Y. J., Xu, M. X. and Wang, F. (1995). "Investigation of pH sensitive drug delivery system of chitosan /gelation hybrid polymer network,"Polym. Int. 38, 77.
273. Yin, Y., Xu, M., Chen. X. and Yao. K. D. (1996). "Drug release behaviour of chitosan gelation network polymer microspheres." Chinese Sci. Bull. 41, 1266-1270.
274. Yuk, S. H., and Bae, Y. H. (1999). "Phase-transition polymers for drag delivery," Cril. Rev, Ther, Drug Can: Syst. 16, 385-423.
275. Zaharoff, D. A., Rogers. C. J., Hance, K. W., Seldom, J. and Greiner. J. W. (2007). "Chitosan solution enhances both humoral and cell-medicated immune responses to subcutaneous vaccination," Vaccine 25, 2085-2094.
276. Zhang, C, Ping, Q., Ding, Y., Cheng, Y., and Shen, J. (2004). "Synthesis, characterization and microsphere formation of galactosylated chitosan," J. Applied Poly. Sci. 91,659-665.
277. Zhang. H. Alsana, I. A., and Neau. S. H. (2002). "An in vitro evaluation of a chitosan-containing multiparticulate system for macromolecular delivery to the colon," Int. J. Pharm. 239. 197-205.
278. Zhao, H. R., Wang, K., Zhao, Y., and Pan, L. Q. (2002). "Novel sustained release implant of herb extract using chitosan," Biomaterials 23. 4459-4462.
279. Zhu, A. P., Ming, Z., and Jian, S. (2005). "Blood compatibility of chitosan heparin complex surface modified ePTFE vascular graft," Applied Surface Science 241, 485-492.
280. Zhu. A., Liu, J. and Ye, W. (2006). "Effective loading and controlled release of camptofiiecin by o-carboxymethylcliitosan aggregates," Carbohydrate Polymers 63(1). 89-96.
281. Zielinski. B. A., and Aebischer, P. (1994). "Chitosan as a matrix for mammalian cell encapsulation," Biomaterials 15, 1049-1056.
282. Zikakis, J. P., Saylor, W. W., and Austin. P. R. (eds.) (1982). Chitin and Chitosan, The Japanese Society of Chitin and Chitosan, Tottori. p. 233.